3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Basal Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Fluorouracil
14
Nivolumab
13
Oxaliplatin
12
Leucovorin
11
Paclitaxel
7
Capecitabine
7
pembrolizumab
6
Radiotherapy
5
Cisplatin
5
Taxes
4
Specimen Handling
4
Radiation
4
Irinotecan
4
Drug Therapy
4
dehydroftorafur
3
Trastuzumab
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Folfox protocol
3
zimberelimab
2
zanidatamab
2
trastuzumab deruxtecan
2
futibatinib
2
Levoleucovorin
2
Endoscopy, Digestive System
2
Endoscopy
2
Carboplatin
2
Biopsy
2
zolbetuximab
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Erlotinib Hydrochloride
×
90 days
×
Clear all
No trials found.